Jacobson Pharma Corporation has entered into a joint supply and distribution agreement with Fosun Industrial for 10 million doses of candidate coronavirus vaccine BioNTech BNT162. If clinical trials are successful, the companies will distribute the vaccine to the Hong Kong Special Administrative Region and Macao District of the People's Republic of China.